149 related articles for article (PubMed ID: 3522315)
1. Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.
Campbell PJ; Gerich JE
Diabetes; 1986 Jul; 35(7):749-52. PubMed ID: 3522315
[TBL] [Abstract][Full Text] [Related]
2. Insulin clearance contributes to the variability of nocturnal insulin requirement in insulin-dependent diabetes mellitus.
Dux S; White NH; Skor DA; Santiago JV
Diabetes; 1985 Dec; 34(12):1260-5. PubMed ID: 3905459
[TBL] [Abstract][Full Text] [Related]
3. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
Arslanian S; Ohki Y; Becker DJ; Drash AL
Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
[TBL] [Abstract][Full Text] [Related]
4. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
[TBL] [Abstract][Full Text] [Related]
6. Alterations in insulin clearance and hepatic blood flow during the night do not contribute to the 'dawn phenomenon' in type 1 diabetes.
Widmer A; Keller U; Pasquel M; Berger W
Horm Res; 1988; 29(5-6):197-201. PubMed ID: 3065206
[TBL] [Abstract][Full Text] [Related]
7. Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
Metabolism; 1985 Dec; 34(12):1100-4. PubMed ID: 3906350
[TBL] [Abstract][Full Text] [Related]
8. The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.
Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
Diabetologia; 1991 Jan; 34(1):21-8. PubMed ID: 2055337
[TBL] [Abstract][Full Text] [Related]
9. Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.
De Feo P; Perriello G; Ventura MM; Calcinaro F; Basta G; Lolli C; Cruciani C; Dell'Olio A; Santeusanio F; Brunetti P
Diabetologia; 1986 Aug; 29(8):475-80. PubMed ID: 3530862
[TBL] [Abstract][Full Text] [Related]
10. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM.
Beck-Nielsen H; Richelsen B; Hasling C; Nielsen OH; Heding L; Sørensen NS
Diabetes; 1984 Sep; 33(9):832-7. PubMed ID: 6381179
[TBL] [Abstract][Full Text] [Related]
11. [Use of the biostator for programming the insulin infusion pump Microjet-Bolus-2 in the treatment of insulin-dependent diabetes mellitus].
Sieradzki J; Szurkowska M
Pol Arch Med Wewn; 1988 May; 79(5):271-7. PubMed ID: 3078197
[No Abstract] [Full Text] [Related]
12. Relative roles of insulin clearance and insulin sensitivity in the prebreakfast increase in insulin requirements in insulin-dependent diabetic patients.
Skor DA; White NH; Thomas L; Santiago JV
Diabetes; 1984 Jan; 33(1):60-3. PubMed ID: 6360768
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
14. [Effect of insulin sensitivity on the occurrence of early-morning hyperglycemia in patients treated with insulin].
Krzymień J; Szymerska E; Tracz M; Regulski M; Jasik M
Pol Arch Med Wewn; 1989 Mar; 81(3):176-82. PubMed ID: 2697868
[TBL] [Abstract][Full Text] [Related]
15. Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.
Dunn FL; Carroll PB; Beltz WF
Diabetes; 1987 May; 36(5):661-6. PubMed ID: 3552799
[TBL] [Abstract][Full Text] [Related]
16. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.
Carroll MF; Hardy KJ; Burge MR; Schade DS
Diabetes Technol Ther; 2002; 4(5):595-605. PubMed ID: 12450440
[TBL] [Abstract][Full Text] [Related]
17. Determination and kinetic analysis of non-insulin mediated glucose uptake in type 1 (insulin-dependent) diabetes mellitus.
Shumak SL; Gulan M; Zinman B; Gottesman IS
Diabetologia; 1989 Jan; 32(1):28-33. PubMed ID: 2651186
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII.
Koivisto VA; Yki-Järvinen H; Helve E; Karonen SL; Pelkonen R
Diabetes; 1986 Jan; 35(1):78-82. PubMed ID: 3510143
[TBL] [Abstract][Full Text] [Related]
19. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
20. [Morning hyperglycemia in children and adolescents with type 1 diabetes and different modes of therapy: an evaluation of the DPV data pool].
Wolf J; Kapellen T; Stachow R; von Schütz W; Holl R
Klin Padiatr; 2012 Nov; 224(7):471-5. PubMed ID: 22915451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
